Skip to main content Back to Top

Standardize 4 Safety: Taking Aim at Strategies for Adoption

Broadcast Date: June 24, 2022


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In this podcast, experts discuss the advantage of using a standardized approach to medication concentrations and strategies for adoption provided from the Standardize 4 Safety initiative.


Deborah WagnerDeborah Wagner, PharmD, FASHP, is a Clinical Professor of Pharmacy and Anesthesiology for the University of Michigan College of Pharmacy and Michigan Medicine Medical School, as well as the Pediatric Safety Coordinator for the Children’s and Women’s Hospital at Michigan Medicine. She completed her B.S. and PharmD degree at the University of Michigan College of Pharmacy. Dr. Wagner has worked with ISMP on the perioperative safety initiative, the Anesthesia Patient Safety Foundation, and the ASHP Standardize 4 Safety Campaign. She is a past member of the ASHP Medication Safety task force and co-author of the ASHP Guidelines on Perioperative Pharmacy Services. She currently chairs the Michigan Medicine Pediatric Medication Safety Committee.

Rachel MeyersRachel Meyers is a Clinical Professor at the Ernest Mario School of Pharmacy at Rutgers University, and the Pediatric Clinical Pharmacist at Cooperman Barnabas Medical Center in Livingston, New Jersey. Dr. Meyers provides both didactic and experiential education in pediatric pharmacotherapy for pharmacy students and residents. Her research interests include pediatric dosage forms and medication safety for children. She practices in both the Pediatric Intensive Care Unit and General Pediatric Unit at Cooperman Barnabas Medical Center.

Mary Ann KliethermesMary Ann Kliethermes, PharmD, FASHP received a BS in pharmacy from the University of Michigan (1977) and Doctor of Pharmacy from the Philadelphia College of Pharmacy and Science (1981). Her 45 year clinical practice includes hospital, home infusion, ambulatory practice and academia. Currently she is Director of Medication Safety and Quality at ASHP. Her expertise is pharmacist reimbursement, medication optimization, safety and quality, and new healthcare models and payment systems.


Relevant Financial Relationship Disclosures

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. 


More in this series

Standardize 4 Safety - Past, Present, and Future of Safer Care

Standardize 4 Safety: How Did It Start and Where Is It Going?

A Plea for Standardization


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Provided by ASHP
Sponsored by Baxter Healthcare Corporation